Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Eleni Efstathiou

Showing results (31-40 of 150) with videos related to

Pageof 15
Sort By:
Urologic Oncology|September 9, 2010
Recurrent seminomas: clinical features and biologic implicationsAvik Som, Rui Zhu, Charles C Guo, et al.
Medicine|September 13, 2021
The protein arginine methyltransferases (PRMTs) PRMT1 and CARM1 as candidate epigenetic drivers in prostate cancer progressionIoanna Maria Grypari, Souzana Logotheti, Vasiliki Zolota, et al.
Oncology|May 13, 2004
Hormonal therapy with letrozole for relapsed epithelial ovarian cancer. Long-term results of a phase II studyChristos A Papadimitriou, Sophia Markaki, John Siapkaras, et al.
Clinical Genitourinary Cancer|February 19, 2022
Association Between Perioperative Chemotherapy and Survival in Men Undergoing Radical Resection for Primary Urethral Urothelial Carcinoma: An Analysis of the National Cancer DatabaseKenan Celtik, Kelvin Lim, Furkan Dursun, et al.
The Breast Journal|May 20, 2003
Atypical medullary breast carcinoma in a family carrying the 5382insC BRCA-1 mutationChristos Kroupis, Evriklia Lianidou, Nikos Goutas, et al.
The Canadian Journal of Urology|August 13, 2013
Clinically atypical seminomas with yolk sac tumor featuresAvik Som, Li Xiao, Rui Zhu, et al.
The Prostate|March 30, 2012
Hedgehog signaling inhibition by the small molecule smoothened inhibitor GDC-0449 in the bone forming prostate cancer xenograft MDA PCa 118bMaria Karlou, Jing-Fang Lu, Guanglin Wu, et al.
Urologic Oncology|December 15, 2015
Expression of α5-integrin, α7-integrin, Ε-cadherin, and N-cadherin in localized prostate cancerAlexandros Drivalos, Michael Chrisofos, Eleni Efstathiou, et al.
Anticancer Research|August 17, 2005
Brain metastases from epithelial ovarian cancer. The Hellenic Cooperative Oncology Group (HeCOG) experience and review of the literatureDimitrios Pectasides, Gerasimos Aravantinos, George Fountzilas, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 24, 2007
Initial modulation of the tumor microenvironment accounts for thalidomide activity in prostate cancerEleni Efstathiou, Patricia Troncoso, Sijin Wen, et al.
Pageof 15

Showing results (31-40 of 150) with videos related to

Sort By:
Pageof 15
Urologic Oncology|September 9, 2010
Recurrent seminomas: clinical features and biologic implicationsAvik Som, Rui Zhu, Charles C Guo, et al.
Medicine|September 13, 2021
The protein arginine methyltransferases (PRMTs) PRMT1 and CARM1 as candidate epigenetic drivers in prostate cancer progressionIoanna Maria Grypari, Souzana Logotheti, Vasiliki Zolota, et al.
Oncology|May 13, 2004
Hormonal therapy with letrozole for relapsed epithelial ovarian cancer. Long-term results of a phase II studyChristos A Papadimitriou, Sophia Markaki, John Siapkaras, et al.
Clinical Genitourinary Cancer|February 19, 2022
Association Between Perioperative Chemotherapy and Survival in Men Undergoing Radical Resection for Primary Urethral Urothelial Carcinoma: An Analysis of the National Cancer DatabaseKenan Celtik, Kelvin Lim, Furkan Dursun, et al.
The Breast Journal|May 20, 2003
Atypical medullary breast carcinoma in a family carrying the 5382insC BRCA-1 mutationChristos Kroupis, Evriklia Lianidou, Nikos Goutas, et al.
The Canadian Journal of Urology|August 13, 2013
Clinically atypical seminomas with yolk sac tumor featuresAvik Som, Li Xiao, Rui Zhu, et al.
The Prostate|March 30, 2012
Hedgehog signaling inhibition by the small molecule smoothened inhibitor GDC-0449 in the bone forming prostate cancer xenograft MDA PCa 118bMaria Karlou, Jing-Fang Lu, Guanglin Wu, et al.
Urologic Oncology|December 15, 2015
Expression of α5-integrin, α7-integrin, Ε-cadherin, and N-cadherin in localized prostate cancerAlexandros Drivalos, Michael Chrisofos, Eleni Efstathiou, et al.
Anticancer Research|August 17, 2005
Brain metastases from epithelial ovarian cancer. The Hellenic Cooperative Oncology Group (HeCOG) experience and review of the literatureDimitrios Pectasides, Gerasimos Aravantinos, George Fountzilas, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 24, 2007
Initial modulation of the tumor microenvironment accounts for thalidomide activity in prostate cancerEleni Efstathiou, Patricia Troncoso, Sijin Wen, et al.
Pageof 15